Optum AI Market Strategy Report - Online Pharmacies

Answer Capsule

Optum holds meaningful AI presence in online pharmacy discovery but converts very little of it into recommendations. The September 2026 LLM Authority Index benchmark shows Optum with a 30.95% raw mention presence rate but only 11.20% valid recommendation coverage, a gap of nearly 20 percentage points. Its top-three recommendation rate is 3.27% and its rank-one rate is just 0.16%, meaning Optum is almost never the first pharmacy AI systems name. The clearest opportunity sits in the Brand Recommendation cluster, where Optum is mentioned as context far more often than it is shortlisted.

Who This Report Is For

This report is for Optum's marketing, brand, and digital strategy leaders, and for pharmacy benefit and health services executives who need to understand how AI search surfaces position Optum against retail and digital pharmacy competitors at the moment buyers form a shortlist.

Report Card

Executive Summary

Optum is visible in AI pharmacy answers but is rarely recommended. Across 643 qualified observations in September 2026, Optum appeared in 199 responses, a raw mention presence rate of 30.95%. Only 72 of those observations produced a valid recommendation, giving Optum a valid recommendation coverage of 11.20%. That is a presence-to-recommendation gap of roughly 20 percentage points, and it is the central finding of this report.

The framing profile is not the problem. Optum recorded 119 positive mentions, 80 neutral mentions, and zero negative mentions, producing a net sentiment score of 0.598. AI systems are not cautioning against Optum. They are simply not choosing it when they name a pharmacy to use.

Placement is where the gap widens further. Optum's top-three recommendation rate is 3.27%, and its rank-one rate is 0.16%, equivalent to a single rank-one recommendation across the entire September dataset. For comparison, Amazon Pharmacy holds a 21.31% rank-one rate. Optum is present in the conversation but is almost never the default answer.

The strongest platform signal for Optum is Google AI Mode, where it recorded 36,386.08 in AI Authority Value and a 12.72% valid recommendation coverage, the highest of any tracked platform. Google AI Overviews followed at 10.29% coverage. Perplexity produced zero valid recommendations for Optum despite 16 mentions, making it the clearest platform-level gap.

The clearest cluster-level gap is structural. All 643 qualified observations in September fell into the Brand Recommendation cluster. The benchmark surfaced no qualified observations in the Pricing & Value or Multi-Brand Comparison clusters, so Optum's performance in cost-driven and head-to-head comparison prompts cannot be assessed at the benchmark level. Those questions require company-level prompt analysis.

Optum's position relative to the category is best described as visible but under-recommended. It sits last among ten tracked brands by top-three rate and rank-one rate, despite ranking higher than Capsule, Honeybee Health, and PillPack on raw mention presence. The gap between presence and recommendation is the specific problem this report addresses.

What Optum Is Winning

Questions This Section Answers

• Where does Optum have genuinely strong AI recommendation signals?
• Which platform produces Optum's strongest recommendation performance?

Optum's clearest win is its framing quality. With 119 positive mentions, 80 neutral mentions, and zero negative mentions, Optum carries a net sentiment score of 0.598. Optum's absence of negative framing is a genuine asset in a category where Walgreens and CVS Pharmacy each recorded nine negative mentions.

Optum's second win is its Google AI Mode performance. At 12.72% valid recommendation coverage on that platform, Optum performs better than its overall average and better than its showing on ChatGPT (17.57%), Copilot (12.50%), or Perplexity (0.00%). Google AI Mode also generated the largest share of Optum's total AI Authority Value at 36,386.08.

A third, narrower win is Optum's average recommended rank of 3.75 when it does receive rank credit. That is a mid-list position, not a strong one, but it indicates that when AI systems do place Optum in a recommendation set, they place it credibly rather than at the bottom.

These are real but limited wins. Optum does not hold a dominant cluster, does not lead on any platform, and does not convert its presence into top-three or rank-one placement at competitive rates.

Where Optum Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Optum get mentioned so often but recommended so rarely?
• On which platforms does Optum appear without converting to recommendations?
• How do competitors within the same mention set displace Optum in recommendations?

The primary gap is recommendation conversion. Optum is mentioned in 30.95% of qualified observations but recommended in only 11.20%. Amazon Pharmacy, by contrast, is mentioned in 92.07% of observations and recommended in 45.57%. The gap between presence and recommendation is far wider for Optum than for the category leader, which suggests Optum's mentions are frequently contextual or comparative rather than recommendation-shaped.

The second gap is rank-one displacement. Optum holds rank-one in 0.16% of observations, a single instance. CVS Pharmacy holds 2.33%, Walgreens holds 1.09%, and Cost Plus Drugs holds 1.40%. Even brands with lower overall coverage than Optum, including PillPack at 2.02% and Capsule at 1.09%, outperform Optum on first-position placement. When AI systems name a single pharmacy, Optum is almost never that answer.

The third gap is platform-specific. Perplexity produced 16 Optum mentions but zero valid recommendations, giving Optum a 0.00% valid recommendation coverage on that platform. Copilot produced a 12.50% coverage rate but only two top-three placements across 72 observations. These are platforms where Optum appears as background context rather than as a recommended option.

The fourth gap is competitive displacement within the same mention set. In the Brand Recommendation cluster, Amazon Pharmacy captured 144,556.56 in AI Authority Value against Optum's 42,124.26. Walgreens captured 96,917.60 and CVS Pharmacy captured 90,833.36. Optum is being mentioned alongside competitors that are being recommended in its place.

Biggest Opportunity

Questions This Section Answers

• What is the highest-impact fix for Optum's recommendation gap?
• Why is Optum's problem a conversion issue rather than an awareness issue?

Optum's single biggest opportunity is converting its existing mention presence into valid recommendation coverage within the Brand Recommendation cluster. Optum already appears in nearly a third of qualified observations. The problem is not that AI systems do not know Optum exists. The problem is that when AI systems assemble a shortlist, Optum is not on it.

The path from reference to recommendation runs through the owned answer layer and the citation architecture behind it. Optum's public evidence layer needs to make the case for Optum as a recommended pharmacy option, not just a recognized health services brand. That means prompt-aligned content that answers the specific questions AI systems are fielding, and source coverage that supports retrievability for recommendation-shaped queries.

This is a conversion problem, not an awareness problem, and it is addressable within the existing presence base.

Competitive Landscape

Questions This Section Answers

• How does Optum compare to other online pharmacies on top-three and rank-one rates?
• Which brands outperform Optum on recommendation placement despite lower visibility?

Amazon Pharmacy holds dominant recommendation-stage strength in online pharmacy discovery, with CVS Pharmacy, Walgreens, and Cost Plus Drugs forming a competitive middle tier. Optum sits in the lower tier by recommendation coverage despite mid-tier raw mention presence, which places it below brands it outranks on visibility alone.

Average recommended rank covers rank-eligible recommendations only.

Optum ranks last among the ten tracked brands on top-three rate and rank-one rate, and its average recommended rank of 3.75 is the weakest in the set. Its sentiment score of 0.598 is mid-tier, ahead of CVS Pharmacy and Walgreens but well behind Honeybee Health, PillPack, and Cost Plus Drugs. The table shows a brand that is mentioned often enough to be visible but is placed last or omitted when AI systems build a shortlist.

Prompt Evidence

Questions This Section Answers

• What do real prompt responses reveal about why Optum is mentioned but not shortlisted?
• Which prompts produced mentions without recommendations for Optum?

Google AI Mode / Brand Recommendation Prompt: "Which is the most reliable online pharmacy?" Result: Optum appeared in the response set with a 12.72% valid recommendation coverage on this platform, its strongest platform-level showing, but was not the first recommendation.

Perplexity / Brand Recommendation Prompt: "prescription delivery service" Result: Optum was mentioned in 16 Perplexity observations but received zero valid recommendations on that platform, appearing as context rather than as a recommended option.

ChatGPT / Brand Recommendation Prompt: "What is the best mail-order pharmacy?" Result: Optum recorded a 17.57% valid recommendation coverage on ChatGPT with no rank-one placements, indicating mid-list presence without first-position strength.

Google AI Overviews / Brand Recommendation Prompt: "How much do miebo eye drops cost?" Result: Optum appeared in the response set with a 10.29% valid recommendation coverage and a single rank-one placement across 175 observations on this platform.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts where Optum is mentioned but not recommended, and identify which competitors take the recommendation in those same responses.

Phase 2: Recommendation Readiness Plan Prioritize the prompt clusters and platforms where Optum's presence-to-recommendation gap is widest, starting with Perplexity and Copilot.

Phase 3: Owned Answer Layer Buildout Build prompt-aligned content that answers the recommendation-shaped questions AI systems field, positioning Optum as a shortlist option rather than a background reference.

Phase 4: Citation / Authority Layer Development Strengthen the public source footprint that AI systems retrieve from, so Optum's recommendation case is supported by retrievable, attributable evidence.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Optum's valid recommendation coverage, top-three rate, and rank-one rate month over month against the competitor set to measure whether presence is converting into placement.

Why This Matters

AI systems are now where pharmacy shortlists form. A buyer asking which online pharmacy is most reliable, which delivers prescriptions, or which handles mail-order refills receives a recommendation set, not a search results page. Optum is in that conversation but is not on the shortlist. That is a decision-stage loss, not a visibility-stage one.

Presence alone does not win the recommendation. Optum's 30.95% mention presence is competitive, but its 11.20% recommendation coverage and 0.16% rank-one rate are not. The next move is targeted correction of the prompt, page, and citation layers that determine whether AI systems name Optum as an option or merely mention it in passing.

Core Metrics

Sentiment Score

Questions This Section Answers

• How should Optum's 199 mentions be interpreted beyond raw volume?
• Why does a healthy sentiment profile not guarantee Optum is recommended?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Optum in September 2026: (119 × 1 + 80 × 0 + 0 × -1) / 199 = 0.598.

This matters because unclassified mention counts are misleading. A brand mentioned 199 times sounds strong until the mentions are separated into positive recommendations, neutral references, and cautionary framing. Optum's 199 mentions break down into 119 positive and 80 neutral, with no negative framing. That is a healthy profile, but it does not mean Optum is being recommended. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, and Optum's classified profile shows a brand that is framed well but chosen rarely.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Optum's position in AI-generated online pharmacy recommendations, produced from the September 2026 LLM Authority Index AI Market Discovery dataset.
2. The reporting window is September 2026, with July 2026 and August 2026 used as comparison periods where the benchmark provides them.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The September 2026 benchmark is based on 643 qualified observations, drawn from a raw collection of 800 prompt-surface observations and 559 unique questions.
5. The competitor universe contains ten tracked brands: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx Care, Honeybee Health, Optum, PillPack (Amazon Pharmacy), and Walgreens.
6. All 643 qualified observations fell into the Brand Recommendation buyer-intent cluster. The benchmark surfaced no qualified observations in the Pricing & Value or Multi-Brand Comparison clusters.
7. A mention is counted when Optum appears anywhere in a qualified AI response, regardless of whether it is recommended.
8. A valid recommendation is counted only when Optum appears in a recommendation-shaped answer, as marked by the dataset. Neutral, cautionary, and comparison-anchor mentions are not counted as valid recommendations.
9. Top-three rate and rank-one rate are calculated against the 643 qualified observations, not the raw collection.
10. Average recommended rank covers rank-eligible recommendations only. Optum's average recommended rank of 3.75 is based on its rank-eligible recommendation set.
11. Brand tracking changed in September 2026. GoodRx and Optum Rx, tracked in July and August, no longer appear as separately tracked brands. GoodRx Care and Optum entered tracking this month. Optum's September figures are not directly comparable to any prior Optum Rx series.
12. Source presence in the underlying dataset is evidence about the information environment. It is not treated as proof that any source caused a recommendation.

See Where AI Is Recommending Your Brand

The public benchmark shows where Optum stands in AI pharmacy recommendations. A company-level AI visibility audit maps the specific prompts, platforms, competitors, and source patterns behind those numbers, and turns them into a prioritized plan for closing the recommendation gap.